作者: M. Cavarelli , G. Scarlatti
DOI: 10.1111/J.1365-2796.2011.02458.X
关键词: Acquired immunodeficiency syndrome (AIDS) 、 Pediatrics 、 Transmission (medicine) 、 Breastfeeding 、 Medicine 、 Virology 、 Pregnancy 、 Mother to child transmission 、 Nevirapine 、 Human immunodeficiency virus (HIV) 、 Regimen
摘要: Abstract. Cavarelli M., Scarlatti G (Unit of Viral Evolution and Transmission, DITID, San Raffaele Scientific Institute). Human immunodeficiency virus type 1 mother-to-child transmission prevention: successes controversies (Symposium). J Intern Med 2011; doi: 10.1111/j.1365-2796.2011.02458.x. The World Health Organization (WHO) United Nations Programme on HIV/AIDS (UNAIDS) estimated that an additional 370 000 new human (HIV-1) infections occurred in children 2009, mainly through (MTCT). Intrapartum contributes to approximately 20–25% infections, utero 5–10% postnatal 10–15% cases. MTCT accounts for only a few hundred infected newborns those countries which services are established voluntary counselling testing pregnant women, supply antiretroviral drugs is available throughout pregnancy with recommendations elective Caesarean section avoidance breastfeeding. The single-dose nevirapine regimen has provided the momentum initiate programmes many resource-limited countries; however, regimens using combination needed also effectively reduce via